Risk of recurrence lower with rivaroxaban than aspirin

被引：0
|
作者：
Karina Huynh
机构：
来源：
Nature Reviews Cardiology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：254 / 255
页数：1
相关论文
共 50 条
  • [1] Venous thromboembolism Risk of recurrence lower with rivaroxaban than aspirin
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 3 - 3
  • [2] Greater Benefit with Rivaroxaban Than Aspirin for Extended Treatment of VTE
    Kulkarni, Nita Shrikant
    AMERICAN FAMILY PHYSICIAN, 2017, 96 (02) : 128 - 128
  • [3] Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial
    Anand, Sonia S.
    Eikelboom, John W.
    Dyal, Leanne
    Bosch, Jackie
    Neumann, Christoph
    Widimsky, Petr
    Avezum, Alvaro A.
    Probstfield, Jeffrey
    Bruns, Nancy Cook
    Fox, Keith A. A.
    Bhatt, Deepak L.
    Connolly, Stuart J.
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (25) : 3271 - 3280
  • [4] Aspirin No Different Than Rivaroxaban for Prevention of VTE After TKA or THA
    Kulkarni, Nita Shrikant
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (04) : 248 - 248
  • [5] In nonvalvular AF, DOAC-related risk for GI bleeding was lower with apixaban than dabigatran or rivaroxaban
    Koretz, Ronald L.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (04) : JC21 - JC21
  • [6] In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleeding
    Dunn, Andrew
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (12) : JC65 - JC65
  • [7] Major bleeding with rivaroxaban and aspirin
    Reactions Weekly, 2019, 1772 (1) : 12 - 12
  • [8] Aspirin Monotherapy Is More Cost Effective than Rivaroxaban plus Aspirin in Peripheral Arterial Disease Patients after Revascularization
    Feldman, Zach M.
    James, Lyndon P.
    McElroy, Imani E.
    Ferket, Bart
    Srivastava, Sunita D.
    Jones, Douglas W.
    Hunink, Myriam G.
    JOURNAL OF VASCULAR SURGERY, 2022, 76 (04) : E101 - E101
  • [9] In embolic stroke of undetermined source, rivaroxaban vs aspirin did not reduce recurrence and increased bleeding
    Frieden, Richard W.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (06) : JC32 - JC32
  • [10] Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study
    Fanning, Laura
    Wong, Ian C. K.
    Li, Xue
    Chan, Esther W.
    Mongkhon, Pajaree
    Man, Kenneth K. C.
    Wei, Li
    Leung, Wai K.
    Darzins, Peteris
    Bell, Simon
    Ilomaki, Jenni
    Lau, Wallis C. Y.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (12) : 1550 - 1561
12345